Soligenix, Inc. (SNGX)
1.595
+0.02
(+0.95%)
USD |
NASDAQ |
Dec 09, 16:00
1.595
0.00 (0.00%)
After-Hours: 19:11
Soligenix EPS Diluted (Quarterly): -0.5846 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Insmed, Inc. | -1.747 |
| Tonix Pharmaceuticals Holding Corp. | -3.587 |
| Citius Oncology, Inc. | -0.075 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.531M |
| Total Expenses (Quarterly) | 2.531M |
| Enterprise Value | 5.796M |
| Earnings Yield | -229.4% |
| Normalized Earnings Yield | -233.65 |